Synthetic virus supports a bat origin for SARS

November 26, 2008

Studies establish response strategy for emerging infections

SARS - severe acute respiratory syndrome - alarmed the world five years ago as the first global pandemic of the 21st century. The coronavirus (SARS-CoV) that sickened more than 8,000 people - and killed nearly 800 of them - may have originated in bats, but the actual animal source is not known.

In an effort to understand how SARS-CoV may have jumped from bats to humans, a team of investigators from Vanderbilt University Medical Center and the University of North Carolina at Chapel Hill has now generated a synthetic SARS-like bat coronavirus. The virus - the largest replicating synthetic organism ever made - is infectious in cultured cells and mice, the researchers report in the Proceedings of the National Academy of Sciences.

The findings identify pathways by which a bat coronavirus may have adapted to infect humans. The studies also provide a model approach for rapid identification, analysis and public health responses to future natural or intentional virus epidemics.

Zoonotic viruses - animal pathogens that can cause disease in humans - pose a serious threat to public health, said Mark Denison, M.D., professor of Pediatrics at Vanderbilt and a co-leader of the research with Ralph Baric, Ph.D., professor of Epidemiology at UNC.

"It's becoming more and more clear that new human epidemics will continue to originate in animals," said Denison, who is also an associate professor of Microbiology & Immunology. "However, the mechanisms of trans-species movement and adaptation of viruses from animals to humans remain poorly understood."

At the time of the SARS epidemic, the culprit virus was rapidly identified as a coronavirus (SARS-CoV). But it didn't look like the two human coronaviruses that were known, which cause 20 percent to 30 percent of common colds, and the animal "reservoir" (the original animal host for the virus) remained elusive.

Investigators became convinced that bats were the likely source, but bat coronaviruses had never been successfully grown in culture or animals, which blocked studies of replication, evolution and prevention.

The Denison and Baric teams, with lead authors Michelle Becker, Ph.D., of Vanderbilt, and Rachel Graham Ph.D., of UNC, determined that not being able to grow the virus represented a critical gap in the ability to rapidly identify and respond to new pathogens.

To address this vulnerability, the team decided to use synthetic biology to recover a non-cultivatable virus.

"The idea is, here's the virus, or the virus group, that we think became SARS-CoV," Denison said. "Let's see if we can synthetically recover the bat virus and test it in cultured cells and in animal models - let the bat virus show us the pathways that it may have used to become a human pathogen.

"Then we would have a viable candidate virus to test for diagnostics, vaccines and treatment."

The investigators used published SARS-like bat coronavirus sequences to establish a "consensus" genome sequence - "the best bet for a virus genome that would be viable," Denison said. They then used commercial DNA synthesis and reverse genetics to "build" the consensus viral genome and several variations.

The consensus synthetic SARS-like bat CoV did not initially grow in culture. But substitution of a single small region from human SARS-CoV - the Spike protein receptor binding domain that is critical for viral entry into human cells - allowed the new chimeric SARS-like bat CoV to grow well in monkey cells (commonly used to study human SARS-CoV).

"It was a tremendous surprise that such a small region of SARS-CoV was sufficient to allow the bat virus to move from zero growth to very efficient growth in cells," Denison said.

The chimeric virus also grew well in mouse cells modified to express the receptor for SARS-CoV and in primary human airway epithelial cells. It grew poorly in mice, but a single additional change in the Spike region allowed efficient growth in mice, without causing a SARS-like disease.

The studies suggest that a very simple recombination event may have been enough to allow a coronavirus to move from one species to another, Denison said, adding that "after a virus gains the capacity to jump species, additional simple adaptations may be adequate to increase its ability to grow in the new animal host."

At all stages of design and implementation, the Vanderbilt and UNC teams acknowledged potential safety concerns and encouraged ongoing external safety reviews. Research with all bat viruses - even weakened mutants - was performed under the same stringent biosafety conditions used to study virulent SARS-CoV. The investigators found that human antibodies known to render SARS-CoV noninfectious also neutralized the bat SARS-like coronavirus, providing an additional safety measure.

"The approaches used here address fundamental questions in virus movement between species," Denison said, "and also could improve public health preparedness by allowing rapid responses to naturally emerging or intentionally introduced zoonotic pathogens."

Vanderbilt University Medical Center

---

---

	Molecular Biology of the SARS-Coronavirus by Sunil K. Lal (Editor) The SARS outbreak in 2002 caused unprecedented devastation and exhibited unusually high rates of morbidity and mortality. For the SARS coronavirus, the transmission vehicle was man. What added to the spread was man’s convenient, rapid and affordable ways of travel that caused the virus to spread globally in a short span of time. The SARS coronavirus jumped the species barrier, similar to many recent zoonotic diseases – avian flu, swine flu, Nipah and encephalitis virus. It is extremely important for us to understand the enemy before it strikes again in order to be able to combat such outbreaks as and when they occur. Molecular mechanisms that the virus exploits within its host and that result in infection and pathogenesis are the key to being able to block its transmission cycle. In...
	Coronavirus Replication and Reverse Genetics (Current Topics in Microbiology and Immunology) by Luis Enjuanes (Editor) Human coronaviruses caused the SARS epidemic that infected more than 8000 people, killing about ten percent of them in 32 countries. This book provides essential information on these viruses and the development of vaccines to control coronavirus infections.
	Expression, Aufreinigung und Kristallisation des nicht-strukturellen Proteins 8 (nsp8) aus dem SARS-Coronavirus (German Edition) by Wilhelm Bohr (Author) Bachelor Thesis aus dem Jahr 2004 im Fachbereich Biologie - Mikro- und Molekularbiologie, Note: 2, Universität zu Lübeck (Institut für Biochemie), 19 Eintragungen im Literaturverzeichnis, Sprache: Deutsch, Anmerkungen: Der Schwerpunkt dieser Arbeit ist die Kristallisation des nicht-strukturellen Protein 8 aus dem SARS-Coronavirus. , Abstract: Im Februar letzten Jahres (2003), wurde bei fast 9000 Personen rund um den Globus SARS diagnostiziert, wovon etwa 800 an den Folgen dieser Krankheit gestorben sind. Auch dieses Jahr sind wieder im Winter einige (~9) Fälle von SARS aufgetreten, die aber auf einen Vorfall in einem Labor in Beijing zurückgeführt werden konnten (www.wpro.who.int/sars). Der neue Coronavirus Typ wurde aus den befallenen Geweben der Patienten isoliert und als der...
	The chairman and the Coronavirus: globalization and China's healthcare system.(World In Review): An article from: Harvard International Review by Betty Ho (Author), Thomas Tsai (Author) This digital document is an article from Harvard International Review, published by Harvard International Relations Council, Inc. on January 1, 2004. The length of the article is 2698 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: The chairman and the Coronavirus: globalization and China's healthcare system.(World In Review) Author: Betty Ho Publication: Harvard International Review (Refereed) Date: January 1, 2004 Publisher: Harvard International Relations Council, Inc. Volume: 25 Issue: 4 Page: 28(4) Distributed by Thomson...
	A la caza del coronavirus: los laboratorios de todo el mundo trabajan a marchas forzadas para conseguir desarrollar test diagn?sticos que permitan ... agudo severo ): An article from: Epoca by Mar?a Corisco (Author) This digital document is an article from Epoca, published by Difusora de Informacion Periodica, S.A. (DINPESA) on May 15, 2003. The length of the article is 1389 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: A la caza del coronavirus: los laboratorios de todo el mundo trabajan a marchas forzadas para conseguir desarrollar test diagn?sticos que permitan detectar de forma r?pida y fiable la presencia del coronavirus en los casos sospechosos. (Sociedad: SARS: nuemon?a asi?tica).(s?ndrome respiratorio agudo severo ) Author: Mar?a Corisco Publication: Epoca...
	New coronavirus may cause 9% of children's respiratory infections.(Infectious Diseases): An article from: Family Practice News by Doug Brunk (Author) This digital document is an article from Family Practice News, published by International Medical News Group on March 15, 2005. The length of the article is 498 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: New coronavirus may cause 9% of children's respiratory infections.(Infectious Diseases) Author: Doug Brunk Publication: Family Practice News (Magazine/Journal) Date: March 15, 2005 Publisher: International Medical News Group Volume: 35 Issue: 6 Page: 31(1) Distributed by Thomson...
	Yale investigators discover novel coronavirus.(Infectious Diseases): An article from: Pediatric News by Doug Brunk (Author) This digital document is an article from Pediatric News, published by International Medical News Group on March 1, 2005. The length of the article is 548 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Yale investigators discover novel coronavirus.(Infectious Diseases) Author: Doug Brunk Publication: Pediatric News (Magazine/Journal) Date: March 1, 2005 Publisher: International Medical News Group Volume: 39 Issue: 3 Page: 9(1) Distributed by Thomson...
	Focus Diagnostics licenses coronavirus CoV-NL63 from Primagen.: An article from: BIOTECH Patent News by Thomson Gale (Publisher) This digital document is an article from BIOTECH Patent News, published by Thomson Gale on September 1, 2005. The length of the article is 508 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Focus Diagnostics licenses coronavirus CoV-NL63 from Primagen. Publication: BIOTECH Patent News (Newsletter) Date: September 1, 2005 Publisher: Thomson Gale Volume: 19 Issue: 9 Distributed by Thomson Gale
	Canine coronavirus: a vaccine can protect your puppy from this contagious illness.: An article from: Dog Watch by Roxanne Snopek (Author) This digital document is an article from Dog Watch, published by Thomson Gale on October 1, 2006. The length of the article is 747 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Canine coronavirus: a vaccine can protect your puppy from this contagious illness. Author: Roxanne Snopek Publication: Dog Watch (Magazine/Journal) Date: October 1, 2006 Publisher: Thomson Gale Volume: 10 Issue: 10 Page: 5(1) Distributed by Thomson...
	Coronavirus: dog-to-dog: the clinical signs may be alarming, but luckily the disease is rarely serious.: An article from: Dog Watch by Tom Ewing (Author) This digital document is an article from Dog Watch, published by Thomson Gale on April 1, 2007. The length of the article is 1314 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Coronavirus: dog-to-dog: the clinical signs may be alarming, but luckily the disease is rarely serious. Author: Tom Ewing Publication: Dog Watch (Magazine/Journal) Date: April 1, 2007 Publisher: Thomson Gale Volume: 11 Issue: 4 Page: 1(2) Distributed by Thomson...